Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Centre Oscar Lambret
SN BioScience
Varian, a Siemens Healthineers Company
I-Mab Biopharma US Limited
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Thomas Jefferson University
Thomas Jefferson University
Revolution Medicines, Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie
Labcorp Corporation of America Holdings, Inc
UNICANCER
University of Michigan Rogel Cancer Center
Cyteir Therapeutics, Inc.
Acepodia Biotech, Inc.
Washington University School of Medicine
Compugen Ltd
Xencor, Inc.
Cedars-Sinai Medical Center
Pfizer
Celldex Therapeutics
STCube, Inc.
Istituti Clinici Scientifici Maugeri SpA
Dana-Farber Cancer Institute
Umeå University
Emory University
Klus Pharma Inc.
Fate Therapeutics
Duke University
Prelude Therapeutics
Quadriga Biosciences, Inc.
Institut de Cancérologie de Lorraine
Xencor, Inc.
Ludwig Institute for Cancer Research
Technische Universität Dresden
Boryung Pharmaceutical Co., Ltd
Roswell Park Cancer Institute
Pfizer
AbbVie
Incyte Corporation
Five Prime Therapeutics, Inc.
Incyte Corporation
Weill Medical College of Cornell University
Wake Forest University Health Sciences
Mie University
Albert Einstein College of Medicine
Ciusss de L'Est de l'Île de Montréal